Evidera
Matt Quaife is a Senior Research Scientist at Evidera since March 2022, following a role as an Assistant Professor in Health Economics at the London School of Hygiene and Tropical Medicine from June 2018 to March 2022. Prior experience includes a position as a Research Fellow in Health Economics at the same institution and an internship with the Behavioural Insights Team associated with Public Health England. Matt's early career involved roles in finance and customer service, including an Assistant Project Accountant at BAE Systems and a Summer Intern at Enterprise Rent-A-Car. Matt holds a Doctor of Philosophy (Ph.D.) in Health Economics from the London School of Hygiene and Tropical Medicine, along with a Master's in Public Health and a Postgraduate Certificate in Learning and Teaching, complemented by a BSc in Business and Financial Economics from the University of Leeds.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.